| Emerging therapeutics for immune tolerance: tolerogenic vaccines, T cell therapy, and IL-2 therapy CD Moorman, SJ Sohn, H Phee Frontiers in immunology 12, 657768, 2021 | 44 | 2021 |
| IFN-β facilitates neuroantigen-dependent induction of CD25+ FOXP3+ regulatory T cells that suppress experimental autoimmune encephalomyelitis D Wang, D Ghosh, SM Islam, CD Moorman, AE Thomason, DS Wilkinson, ... The Journal of Immunology 197 (8), 2992-3007, 2016 | 24 | 2016 |
| Partial CD25 Antagonism Enables Dominance of Antigen-Inducible CD25high FOXP3+ Regulatory T Cells As a Basis for a Regulatory T Cell-Based Adoptive … DS Wilkinson, D Ghosh, RA Nickle, CD Moorman, MD Mannie Frontiers in immunology 8, 1782, 2017 | 19 | 2017 |
| Tolerogenic vaccines: Targeting the antigenic and cytokine niches of FOXP3+ regulatory T cells MD Mannie, KB DeOca, AG Bastian, CD Moorman Cellular immunology 355, 104173, 2020 | 11 | 2020 |
| A GMCSF-Neuroantigen Tolerogenic Vaccine Elicits Systemic Lymphocytosis of CD4+ CD25high FOXP3+ Regulatory T Cells in Myelin-Specific TCR Transgenic … CD Moorman, AD Curtis, AG Bastian, SE Elliott, MD Mannie Frontiers in Immunology 9, 3119, 2019 | 10 | 2019 |
| A GM-CSF-neuroantigen tolerogenic vaccine elicits inefficient antigen recognition events below the CD40L triggering threshold to expand CD4+ CD25+ FOXP3+ Tregs that inhibit … CD Moorman, AG Bastian, KB DeOca, MD Mannie Journal of Neuroinflammation 17 (1), 1-19, 2020 | 7 | 2020 |
| Low-Zone IL-2 Signaling: Fusion Proteins Containing Linked CD25 and IL-2 Domains Sustain Tolerogenic Vaccination in vivo and Promote Dominance of FOXP3+ Tregs … KB DeOca, CD Moorman, BL Garcia, MD Mannie Frontiers in Immunology 11, 541619, 2020 | 6 | 2020 |
| GMCSF-neuroantigen vaccines engender FOXP3+ regulatory T cell responses through low-efficiency self-antigen recognition events integrated through diminished CD40L-CD40 signaling CD Moorman, MD Mannie The Journal of Immunology 202 (1_Supplement), 193.3-193.3, 2019 | | 2019 |
| A Single-Chain Gmcsf-Mog Tolerogenic Vaccine Expands Mog-Specific CD25+ FOXP3+ Regulatory T Cells through Low-Efficiency Antigen Recognition Events to Inhibit Experimental … CD Moorman East Carolina University, 2019 | | 2019 |
| GMCSF-MOG abrogates experimental autoimmune encephalomyelitis (EAE) through the induction of MOG-specific regulatory T-cells. CD Moorman, AD Curtis, MD Mannie The Journal of Immunology 198 (1_Supplement), 72.3-72.3, 2017 | | 2017 |
